NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, today announced that the first patient has been successfully imaged in a Phase 2 clinical trial evaluating the diagnostic accuracy and ...

Researchers have developed and validated a 45-gene transcriptomic signature, Met-Score, that quantifies metastatic competence ...

A 58-year-old businessman walks into a clinic for a routine health check. He feels fine. No pain, no urinary trouble, nothing ...

“It should be protocol that 100% of your patients with metastatic prostate cancer get germline testing. Full stop. No exceptions,” said Neal D. Shore, MD, FACS.

Prostate cancer has a well-earned reputation for being one of the more trackable malignancies in medicine. Since the mid-1980s, a single blood test measuring prostate-specific antigen, or PSA, has ...

Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.

For the retrospective study, researchers evaluated 79 men with suspected clinically significant prostate cancer and PSA ...

Canadian engineers used dead mosquito mouthparts as tiny 3D printer nozzles, enabling new possibilities in microscopic ...

Public information from 10:01:59 on September 23, 2026, to 10:01:59 on September 30, 2026 (Japan Standard Time).This week ...

Cochlear rival MED-EL has launched its totally implantable hearing device in Europe – and investors are listening. ... Read ...

PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...

For a man facing a prostate biopsy, an MRI scan can give doctors a clearer idea of where to look for cancer before they ...